Ann Arbor, MI, United States of America

Brian Tobias

This inventor holds 2 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 2004-2006.


% Patents Active = 50.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brian Tobias: Innovator in Pharmaceutical Compounds

Introduction

Brian Tobias is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various central nervous system disorders. With a total of 2 patents to his name, Tobias continues to push the boundaries of innovation in medicine.

Latest Patents

Tobias's latest patents include the development of pregabalin lactose conjugate compounds. This invention provides a novel method for addressing central nervous system disorders, including seizure disorders, pain, depression, anxiety, sleep disorders, consumptive disorders, psychosis, tardive dyskinesia, Huntington's disease, and Parkinson's disease. The method involves administering a pharmaceutically effective amount of a pregabalin lactose conjugate to the subject. Additionally, he has described new crystalline anhydrous forms of gabapentin, which are formed from gabapentin monohydrate. These new crystalline forms offer advantages in the manufacturing process of the therapeutic agent.

Career Highlights

Brian Tobias is currently associated with Warner-Lambert Company, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing therapeutic options for patients suffering from complex neurological conditions.

Collaborations

Tobias has collaborated with esteemed colleagues, including Linna R Chen and Suresh R Babu, to further enhance the impact of his research and inventions.

Conclusion

Brian Tobias stands out as a dedicated inventor in the pharmaceutical industry, with a focus on developing innovative solutions for central nervous system disorders. His contributions continue to shape the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…